CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
112.75
1.23%
Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.40
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.018641 %
Charges from full value of position ($-3.54)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.018641%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.003582 %
Charges from full value of position ($-0.68)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.003582%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency EUR
Margin 5.00%
Stock exchange France
Commission on trade 0%

Key Stats
Prev. Close 114.15
Open 114.15
1-Year Change 10.5%
Day's Range 112.25 - 114.25
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 21, 2025 112.75 -1.10 -0.97% 113.85 114.55 112.25
Feb 20, 2025 114.15 0.30 0.26% 113.85 114.25 112.35
Feb 19, 2025 113.55 -0.10 -0.09% 113.65 114.45 112.95
Feb 18, 2025 113.95 -1.50 -1.30% 115.45 115.45 113.85
Feb 17, 2025 115.15 0.80 0.70% 114.35 115.65 113.15
Feb 14, 2025 113.85 1.80 1.61% 112.05 114.45 112.05
Feb 13, 2025 114.05 0.40 0.35% 113.65 114.35 112.65
Feb 12, 2025 113.45 -0.50 -0.44% 113.95 114.55 111.95
Feb 11, 2025 114.45 -0.30 -0.26% 114.75 115.25 114.05
Feb 10, 2025 114.95 2.00 1.77% 112.95 115.45 111.45
Feb 7, 2025 113.05 0.50 0.44% 112.55 114.35 112.45
Feb 6, 2025 113.85 -1.30 -1.13% 115.15 116.75 113.55
Feb 5, 2025 116.65 2.40 2.10% 114.25 117.15 113.95
Feb 4, 2025 116.05 -0.60 -0.51% 116.65 117.35 115.75
Feb 3, 2025 116.55 2.70 2.37% 113.85 117.45 113.85
Jan 31, 2025 116.85 0.50 0.43% 116.35 117.35 116.25
Jan 30, 2025 116.65 2.20 1.92% 114.45 116.95 114.45
Jan 29, 2025 115.85 -0.80 -0.69% 116.65 116.75 115.55
Jan 28, 2025 116.85 3.00 2.64% 113.85 116.95 113.85
Jan 27, 2025 114.05 2.00 1.78% 112.05 114.35 112.05

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Biomerieux Company profile

About BioMerieux SA

Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, BioMerieux SA revenues increased 8% to EUR3.38B. Net income applicable to common stockholders increased 49% to EUR601.1M. Revenues reflect Microbiology segment increase of 12% to EUR1.06B, Molecular Biology segment increase of 5% to EUR1.27B, Europe & Middle East & Africa (EMEA) (Region) segment increase of 10% to EUR1.12B, America segment increase of 5% to EUR1.67B.

Equity composition

9/2017, 3-for-1 stock split (Factor: 3).

Industry: Laboratory Diagnostic & Testing Substances

376, chemin de l'Orme
CRAPONNE
AUVERGNE-RHONE-ALPES 69280
FR

People also watch

ETH/USD

2,779.27 Price
+5.290% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Gold

2,936.56 Price
-0.110% 1D Chg, %
Long position overnight fee -0.0149%
Short position overnight fee 0.0067%
Overnight fee time 22:00 (UTC)
Spread 0.30

US100

21,594.40 Price
-2.120% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0013%
Overnight fee time 22:00 (UTC)
Spread 7.0

BTC/USD

96,674.75 Price
+1.390% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 690,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading